Researchers engineered the first injectable microtissue containing motor and sensory neurons encased in protective tissue, called tissue engineered neuromuscular interfaces (TE-NMIs). The TE-NMI neurons provide a source of ...
Apr 5, 2022
0
21
Electrical synapses are omnipresent and yet hardly explored. They are part of the brain of almost every animal species, yet they remain usually invisible even under the electron microscope.
Apr 5, 2022
0
299
Nancy Damato walked past a garbage can the other day and caught a whiff of decaying banana peel.
Apr 5, 2022
0
6
Neurexin, associated with neurodevelopmental disorders, is an essential molecule for the survival of nerve cells called cerebellar granule cells in the cerebellum. A new study revealed that neurexin regulates the survival ...
Apr 5, 2022
0
84
The lethargy that many Alzheimer's patients experience is caused not by a lack of sleep, but rather by the degeneration of a type of neuron that keeps us awake, according to a study that also confirms the tau protein is behind ...
Apr 4, 2022
0
857
In experiments on mice, researchers at ETH Zurich show that non-essential amino acids act as appetite suppressants and promote the urge to move. Their research is published in Current Biology and provides insight into the ...
Apr 1, 2022
0
66
Cognitive decline during normal aging is exacerbated in neurodegenerative disease including Alzheimer's disease (AD). While it is not yet known exactly what causes AD, there are a number of risk factors that make a person ...
Mar 31, 2022
0
77
An investigational device called a brain-computer interface has been found safe in a small study of people with paralysis from ALS, and has allowed participants to use a computer to communicate by text and do daily tasks ...
Mar 29, 2022
0
7
If the blood supply to your brain decreases, it can trigger Alzheimer's disease. Scientists at UiO wanted to find out whether this leads to more or fewer blood vessels and what role one particular protein plays in such a ...
Mar 29, 2022
1
97
Federal health regulators issued a negative review Monday of a closely watched experimental drug for the debilitating illness known as Lou Gehrig's disease, after months of lobbying by patient advocates urging approval.
Mar 28, 2022
0
11
